Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers

Clinical trial NCT05353179 · UNKNOWN

Trial details

NCT number: NCT05353179
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Granulomatosis With Polyangiitis Hemophagocytic Syndrome

Start date: 2022-06-01
Primary completion: 2022-10-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.